BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4571915)

  • 1. Application of cell culture in studying antibacterial activity of rifampicin to Shigella and enteropathogenic Escherichia coli.
    Osada Y; Nakajo M; Une T; Ogawa H; Oshima Y
    Jpn J Microbiol; 1972 Nov; 16(6):525-33. PubMed ID: 4571915
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of subinhibitory concentrations of antimicrobial agents on virulence factors of Shigella flexneri 2a and Escherichia coli O124.
    Tetz VV; Norman LL
    J Med Microbiol; 1994 Oct; 41(4):279-81. PubMed ID: 7932621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [General effects of antibiotic associations on certain Enterobacteriaceae (Escherichia, Salmonella, Klebsiella)].
    Cluzel R; Michel J; Cluzel M; Sirot J
    Pathol Biol (Paris); 1971; 19(11):627-36. PubMed ID: 4933627
    [No Abstract]   [Full Text] [Related]  

  • 4. Transferable multiple drug resistance of shigella strains isolated in Sweden.
    Urban T
    Scand J Infect Dis; 1972; 4(3):221-7. PubMed ID: 4565771
    [No Abstract]   [Full Text] [Related]  

  • 5. Application of experimental keratoconjunctivitis shigellosa in chemotherapeutic evaluation of rifampicin to bacillary dysentery.
    Osada Y; Nakajo M; Ogawa H
    Jpn J Microbiol; 1972 Jul; 16(4):329-32. PubMed ID: 4569214
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibiotic resistance in Shigella mediated by R factors.
    Farrar WE; Eidson M
    J Infect Dis; 1971 May; 123(5):477-84. PubMed ID: 4329896
    [No Abstract]   [Full Text] [Related]  

  • 7. [Occurrence of cultures with episomal resistance to antibiotics among shigellae isolated in Kiev].
    Bass TM
    Antibiotiki; 1974 Jan; 19(1):44-6. PubMed ID: 4377085
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of cell to cell transfer of Shigella by treatment with some antibiotics.
    Osada Y; Une T; Ogawa H
    Jpn J Microbiol; 1973 May; 17(3):233-5. PubMed ID: 4579572
    [No Abstract]   [Full Text] [Related]  

  • 9. An epidemic-associated episome?
    Gangarosa EJ; Bennett JV; Wyatt C; Pierce PE; Olarte J; Hernandes PM; Vázquez V; Bessudo D
    J Infect Dis; 1972 Aug; 126(2):215-8. PubMed ID: 4559853
    [No Abstract]   [Full Text] [Related]  

  • 10. R-factors and behavior of their determinants in strains of enterobacteria of different origins.
    Kheinaru AL; Tallmeister ET
    Sov Genet; 1973 Jul; 7(1):94-102. PubMed ID: 4612731
    [No Abstract]   [Full Text] [Related]  

  • 11. In-vitro susceptibility of E. coli, Shigellae and Salmonellae to kanamycin and therapeutic implications.
    Nelson JD; Haltalin KC
    Ann N Y Acad Sci; 1966 Jun; 132(2):1006-12. PubMed ID: 5336392
    [No Abstract]   [Full Text] [Related]  

  • 12. Patterns of organisms in disease and in vitro sensitivity to kanamycin in comparison with other antibiotics.
    Fujii R
    Ann N Y Acad Sci; 1966 Jun; 132(2):776-95. PubMed ID: 4960371
    [No Abstract]   [Full Text] [Related]  

  • 13. [Distribution of episomal resistance to antibiotics in the causative agents of dysentery].
    Civolodskiĭ EP
    Antibiotiki; 1970 Sep; 15(9):797-801. PubMed ID: 4923138
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antibiotic resistance of "Shigella" isolated in France in 1971. Modifications and stable characteristics].
    Szturm-Rubinsten S; Piéchaud D; d' Hauteville H
    Ann Inst Pasteur (Paris); 1972 Aug; 123(2):307-10. PubMed ID: 4570555
    [No Abstract]   [Full Text] [Related]  

  • 15. Resistance of Shigella flexneri to tetracyclines, chloramphenicol and streptomycin; a study of 131 freshly isolated strains.
    OLARTE J; DE LA TORRE JA
    Am J Trop Med Hyg; 1959 May; 8(3):324-6. PubMed ID: 13661531
    [No Abstract]   [Full Text] [Related]  

  • 16. Virulence of rifampicin-resistant mutants of Shigella and enteropathogenic Escherichia coli with special reference to their cell invasiveness.
    Osada Y; Une T; Nakajo M; Ogawa H
    Jpn J Microbiol; 1973 Jul; 17(4):243-9. PubMed ID: 4200705
    [No Abstract]   [Full Text] [Related]  

  • 17. [Sensitivity to antibacterial preparations of the causative agents of intestinal infections in Transcarpathia. II. Shigella and enteropathogenic Escherichia].
    Grishchenko RI; Sakal' NN; Drozd SI; Kishko AM
    Mikrobiol Zh (1978); 1980; 42(1):91-7. PubMed ID: 6988685
    [No Abstract]   [Full Text] [Related]  

  • 18. [Increase in the incidence of drug resistance transmission in bacteria during agglutination].
    Rapoport LG
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Nov; 48(11):27-31. PubMed ID: 4944339
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on resistance transfer factors. II. Transmissible resistance to eight antibacterial drugs in a strain of Escherichia coli.
    Kontomichalou P
    Pathol Microbiol (Basel); 1967; 30(2):185-200. PubMed ID: 5340264
    [No Abstract]   [Full Text] [Related]  

  • 20. [Microbiological studies on the combination effect of rifampicin and nalidixic acid (author's transl)].
    Ishiyama M; Nakazawa S
    Jpn J Antibiot; 1974 Oct; 27(5):643-52. PubMed ID: 4218271
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.